Transfer of Malignant Traits As Opposed to Migration of Cells: A Novel Concept to Explain Metastatic Disease
Overview
Affiliations
Metastatic disease is believed to develop following dissemination of cells to target organs. Inability of this theory to effectively explain certain phenomena such as patterns of metastatic spread, late metastasis formation, different gene patterns between primary cancer and metastasis have brought forward the need for alternative models. Recent discoveries have strengthened the validity of theories supporting a humoral transfer of malignant traits as opposed to migration of malignant cells to explain metastatic disease in cancer patients. In light of this new evidence, we would like to highlight a model that offers a new perspective to explain cancer metastasis. In the system that we theorize, genetic material released by cancer cells would travel, either free or packed in exosomes, through the blood. Target cells located in organs deriving from the same embryological layer might uptake this genetic material due to expression of specific receptors. Interplay with the immune system would determine the fate of these oncofactors and would regulate their ability to circulate in the blood, integrate in the genome and be transcribed. We also hypothesize that the expression of cell membrane receptors such as integrins, to which cancer exosomes ligate might be mediated by inherited or acquired oncosuppressor mutations.
Witz A, Dardare J, Betz M, Gilson P, Merlin J, Harle A Clin Exp Med. 2024; 24(1):2.
PMID: 38231464 PMC: 10794481. DOI: 10.1007/s10238-023-01278-9.
Cellular Adaptation Takes Advantage of Atavistic Regression Programs during Carcinogenesis.
Gnocchi D, Nikolic D, Paparella R, Sabba C, Mazzocca A Cancers (Basel). 2023; 15(15).
PMID: 37568758 PMC: 10416974. DOI: 10.3390/cancers15153942.
Horizontal Transfer of Malignant Traits and the Involvement of Extracellular Vesicles in Metastasis.
Arena G, Forte S, Abdouh M, Vanier C, Corbeil D, Lorico A Cells. 2023; 12(12).
PMID: 37371036 PMC: 10297028. DOI: 10.3390/cells12121566.
Effects of the Exposure of Human Non-Tumour Cells to Sera of Pancreatic Cancer Patients.
Sabanovic B, Giulietti M, Cecati M, Spolverato G, Benna C, Pucciarelli S Biomedicines. 2022; 10(10).
PMID: 36289850 PMC: 9599555. DOI: 10.3390/biomedicines10102588.
Cell death analysis of recombinant mature epsilon toxin on the kidney cell line.
Chehreara R, Karizi S, Mahmoodzadeh Hosseini H, Mirhosseini S, Shafiei M, Amani J Iran J Microbiol. 2022; 13(6):832-838.
PMID: 35222862 PMC: 8816699. DOI: 10.18502/ijm.v13i6.8088.